METHOD OF PREVENTING OR TREATING BODY WEIGHT DISORDERS BY EMPLOYING CLUSTERIN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100256057A1
SERIAL NO

12599135

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Clusterin possesses an excellent anorexigenic effect and, accordingly, is useful for treating or preventing obesity or an obesity-related disorder. Co-administration of sub-clinical dose of clustrin potentiates the anorexigenic effect of leptin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION93 DAEHAK-RO NAM-GU ULSAN 44610

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Churl, Namkoong Seoul, KR 1 0
Jang, Pil-Geurn Gyeonggi-do, KR 1 0
Kim, Min-Seon Seoul, KR 27 73
Yoon, Byung-Soo Seoul, KR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation